All of the dynamics around GLP-1s, compounding shortage workarounds, and potential for DTC telehealth fallout I described last August seem to be playing out in 2025
On one side, there are brand-name medications like Wegovy, Ozempic, Mounjaro, and Zepbound manufactured by Novo Nordisk and Eli Lilly, FDA-approved, and widely advertised
Potential Side Effects and Risks of GLP-1 RAs Whilst highly effective, GLP-1 receptor agonists are not without side effects
For people with PCOS or insulin resistance, this can help regulate previously irregular cyclesbut it can also take time for your body to adjust
Understanding the long-term outcomes is critical for groups who are considering adding these therapies to coverage for weight loss so they can assess whether covering the cost of these therapies for their employees is affordable when long-term adherence and reduction in medical spend has yet to be established. Blue Cross and Blue Shield of Kansas continuously monitors the pharmacy landscape to determine the best course of care for members
Supplied as a lyophilised (freeze-dried) powder, Retatrutide maintains stability during storage and transport, making it suitable for in vitro studies, analytical testing, and experimental workflows